Energenesis Biomedical Co Ltd
TWSE:6657
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Energenesis Biomedical Co Ltd
TWSE:6657
|
TW |
Wall St Price Targets
Price Targets Summary
Energenesis Biomedical Co Ltd
According to Wall Street analysts, the average 1-year price target for Energenesis Biomedical Co Ltd is 43.86 TWD with a low forecast of 43.43 TWD and a high forecast of 45.15 TWD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Energenesis Biomedical Co Ltd's stock price target?
Price Target
43.86
TWD
According to Wall Street analysts, the average 1-year price target for Energenesis Biomedical Co Ltd is 43.86 TWD with a low forecast of 43.43 TWD and a high forecast of 45.15 TWD.
What is the Revenue forecast for Energenesis Biomedical Co Ltd?
Projected CAGR
6%
Over the last 9 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 1 year is 6%.
What is the Gross Profit forecast for Energenesis Biomedical Co Ltd?
Projected CAGR
5%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 1 year is 5%.
